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ABSTRACT
Michelle Torok: The Effect of Vaginal Lactobacilli and Estrogen on Trichomoniasis in
Non-Pregnant Women
(Under the direction of William C. Miller)
This research focused on the effect of vaginal lactobacilli and estrogen on
trichomoniasis. Vaginal lactobacilli were evaluated by vaginal Gram stain, using
criteria described by Nugent [1]. Women with 30 large Lactobacillus spp.
morphotypes per oil immersion field were classified as having higher vaginal
lactobacilli levels. Women with 30 large Lactobacillus spp. morphotypes per oil
immersion field were classified as having lower levels. After adjusting for age,
race/ethnicity, education, concurrent bacterial vaginosis (BV), concurrent gonorrhea
and/or syphilis, number of sex partners in the past 2 months, number of times the
woman has sex in an average week, and oral contraceptive (OC) use, low levels of
vaginal lactobacilli were positively associated with Trichomonas vaginalis (Tv)
among women with greater than a high school education (odds ratio [OR]=4.6; 95%
confidence intervals [CI], 2.2-9.7). Trichomonas vaginalis was not associated with
low levels of lactobacilli among women with less than or equal to a high school
education in multivariable analysis (OR=1.5; 95% CI, 0.7-3.5).
The association between OC use and Tv was also estimated. Women who
reported using OC with their most recent and/or frequent sexual partners were
categorized as using OC. Women who did not report using OC with their most
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recent and/or frequent sexual partner were classified as not using OC. After
adjusting for race/ethnicity, highest educational level attained, condom use,
concurrent BV, level of vaginal lactobacilli, number of sex partners in the past year
and number of times the woman has sex in an average week, OC was moderately
protective against Tv (OR= 0.6, 95% CI 0.3-1.0).
These data suggest that trichomoniasis may be influenced by level of vaginal
lactobacilli and OC use.
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CHAPTER 1: INTRODUCTION
Trichomoniasis is thought to be the most common curable sexually
transmitted infection (STI) in the world [2]. The prevalence of Trichomonas vaginalis
(Tv) infection in women in the United States (US) ranges from 6%-54%, depending
on the population being studied [3]. In US men, the range of prevalence is between
3% and 58%, although there have been fewer studies of men compared to women
[3]. Health complications related to trichomoniasis for both men and women exist,
and infection with Tv is a risk factor for human immunodeficiency virus (HIV)
transmission [4]. Despite the public health importance of this infection, until recently
trichomoniasis has received little clinical and research attention. For example,
though it is known that the vaginal microenvironment can influence acquisition,
presence, clinical presentation and detection of STIs, this has not been well-studied
in trichomoniasis. For this dissertation, we examined the association between
trichomoniasis in women and two factors that affect the vaginal microenvironment:
vaginal lactobacilli and estrogen.
Specific Aims
Specific Aim1
Evaluate the association between Lactobacillus spp. vaginal Gram stain score
and trichomoniasis
2Hypothesis: Decreased Lactobacillus spp. vaginal Gram stain score is
associated with increased frequency of trichomoniasis.
Overview: We compared Lactobacillus spp. vaginal Gram stain scores
between women with and without trichomoniasis.
Rationale: Evaluation of the association between Lactobacillus spp. vaginal
Gram stain score and trichomoniasis could improve our understanding of this
infection and may have implications for management of trichomoniasis.
Specific Aim 2
Assess the association between exogenous estrogen and trichomoniasis
among women
Hypothesis: Trichomoniasis diagnosis is less frequent among women using
estrogen-containing contraceptives.
Overview: We compared OC use between women who tested negative for Tv
and those who tested positive for the pathogen.
Rationale: Previous studies have reported conflicting results about OC use
and risk of trichomoniasis [5-8] as well as the role of estrogen in Tv virulence [9, 10].
Assessing the impact of contraceptive use on STI status is important because it may
influence a woman’s contraceptive choice. Furthermore, contraceptive use may
potentially influence transmission of HIV type 1 infection, since trichomoniasis is a
risk factor for HIV.
Background and Significance
3Once believed to be a benign infection, trichomoniasis—the world’s most
common non-viral STI—is now recognized as a major health problem. Fifteen years
ago, a well-known medical text stated the effect of trichomoniasis on pregnancy was
minimal, the cancer-causing potential for Tv was insignificant and that no clinical
sequlae to the infection were known [11]. However, current research shows a
relationship between trichomoniasis and many health problems in women including:
• postoperative infections
• tubal infertility
• pelvic inflammatory disease (PID)
• preterm birth
• premature rupture of the membranes
• low birth weight and
• cervical cancer [12-18]
Trichomoniasis has also been identified as a risk factor for HIV-1 transmission
[4, 19, 20]. Trichomonas vaginalis may amplify HIV transmission by augmenting HIV
shedding, expanding systemic access through lesions, and increasing the number of
HIV target cells [4, 19, 21]. This suggests a substantial impact on HIV incidence
among subgroups, such as black women, in whom trichomoniasis is common [19].
In 1999, the estimated annual incidence of trichomoniasis worldwide was
approximately 173 million new cases [22, 23]; in the US, there were an estimated
7.4 million new cases in 2000 [24]. Prevalence estimates vary according to the
population studied, from 3% in a student health center to 48% in a juvenile detention
center [19]. In general, prevalence in US STD clinics is thought to be about 25%
4[15]. First described almost 200 years ago, only now is trichomoniasis beginning to
receive the attention it deserves as a major health hazard [11].
Vaginal lactobacilli and trichomoniasis
How the local vaginal milieu affects the occurrence of trichomoniasis is not
known. Lactobacilli, the predominant microorganism in the healthy human vagina,
are affected by many factors: sexual behavior, hormones, presence of blood,
presence of foreign bodies (e.g. tampons) and medications/preparations (e.g.
antibiotics or douching agents) [25, 26]. All lactobacilli produce lactic acid and some
produce hydrogen peroxide (H2O2). Production of these compounds, via anaerobic
metabolism of vaginal glycogen by lactobacilli, may protect against cervico-vaginal
infection and may influence virulence of cervico-vaginal pathogens [27-29]. Thus,
women with decreased or absent lactobacilli may be more likely to acquire or have
cervico-vaginal infections.
Furthermore, hormones can affect the vaginal microenvironment, but this
complex relationship is not well understood [30]. Currently, we know only that
biological interaction between endogenous and exogenous sex hormones and
trichomoniasis may occur, potentially impacting the presence of disease.
Epidemiologic evidence supports a relationship between vaginal lactobacilli
and other cervico-vaginal conditions. In prospective studies, acquisition of bacterial
vaginosis (BV) (hazard ratio [HR]=4.0, p<0.001), gonorrhea (HR=1.7, 95% CI: 1.1-
2.6) and HIV-1 (HR=2.0, 95% CI:1.2-3.5) [26, 27] have been associated with lack of
vaginal lactobacilli. Cross-sectional studies have also found associations between
5decreased vaginal lactobacilli and presence of cervico-vaginal conditions including
HIV-1, Group B streptococci, chlamydia and gonorrhea [31-33]. A number of studies
have attempted to determine if H2O2 -producing lactobacilli inhibit growth of genital
microorganisms.
Results from a cross-sectional study among a cohort of pregnant women
showed those colonized by H2O2-positive lactobacilli were less likely to have BV and
symptomatic candidiasis compared to women with H2O2-negative lactobacilli
(p<0.05). Researchers from the same study also observed that women with H2O2-
positive lactobacilli were less likely to have chlamydia compared to women with no
vaginal lactobacilli (p<0.05) [31]. Similarly, in a longitudinal study conducted in
women attending an STI clinic, acquisition of BV was associated with lack of vaginal
H2O2-positive lactobacilli (HR=4.0, p<0.001) and presence of only H2O2-negative
lactobacilli (HR=2.2, p=0.02) [27]. However, investigators from another longitudinal
study failed to find a statistically significant association between acquisition of
gonorrhea or HIV-1 among women with only H2O2-negative lactobacilli compared to
women colonized with H2O2-positive lactobacilli. They did report an association
between acquisition of HIV-1 among women without vaginal lactobacilli compared to
women colonized with H2O2-positive lactobacilli (HR=2.8, 95% CI: 1.1-4.7) [26].
Whether vaginal lactobacilli level is associated with trichomoniasis is not
known. In vitro and clinical data suggest an association between the two vaginal
microorganisms. Research has shown that addition of lactobacilli to Tv culture
slows growth of the protozoa [34]. T. vaginalis is also known to phagocytize
6lactobacilli [35, 36]. Furthermore, lactobacilli have been used to treat trichomoniasis
in women, although this remedy may not be efficacious [37, 38].
The epidemiologic data concerning trichomoniasis and vaginal lactobacilli
also suggest an association but are not clear. Trichomoniasis was associated with
an alkaline vaginal pH (resulting from decreased numbers of lactobacilli) in several
early studies [39, 40]. This association was confirmed in univariable analyses of
several later studies [41-44]. For example, Hillier et al (1991) reported pregnant
women with lactobacilli-predominant vaginal flora were less likely to be infected with
Tv compared to women with reduced lactobacilli or BV (p< 0.001) [32]. The most
compelling results came from a cross-sectional study among pregnant women at a
prenatal clinic in South Africa. In this study, women with decreased levels of vaginal
lactobacilli were much more likely to have trichomoniasis compared to women with
higher levels of vaginal lactobacilli (OR=7.8, 95% CI: 4.0-15.2) [41]. These studies
suggest an association between vaginal lactobacilli and trichomoniasis.
Researchers investigating H2O2 -producing lactobacilli and STIs have also
examined trichomoniasis. In a cross-sectional study, women with H2O2-negative
vaginal lactobacilli were as likely to be colonized by Tv as women without vaginal
lactobacilli. However, a statistically nonsignificant trend toward increased frequency
of infection in women with H2O2-positive, H2O2-negative and no vaginal lactobacilli,
respectively, was observed [31]. In a prospective cohort study, presence of H2O2-
positive lactobacilli (compared to no vaginal lactobacilli and presence of H2O2-
negative vaginal lactobacilli) did not appear to protect against acquisition of
trichomoniasis [27]. Similarly, a prospective cohort study among sex workers in
7Africa failed to find a statistically significant association between absence of
lactobacilli compared to presence of H2O2-positive lactobacilli and acquisition of
trichomoniasis (HR=1.4, 95% CI: 0.9-2.1) [26]. Therefore, an association between
vaginal lactobacilli and trichomoniasis is questionable.
Discrepant study results may be due to use of different Tv diagnostic
methods: wet mount microscopy [26, 39, 45], Tv culture [27, 40, 43], wet mount
microscopy and Tv culture [31, 32, 42, 44, 46] and Pap smear [41]. Some of these
studies suffered from small sample sizes as well. For example, one study in which
vaginal lactobacilli did not appear to protect against acquisition of trichomoniasis
included only 7 cases of the infection, another had only 27 cases [27, 31]. Another
explanation for inconsistent results is that most studies failed to assess the influence
of covariables on the relationship between vaginal lactobacilli and trichomoniasis.
For example, age, race, date of last vaginal sex, douching frequency, douching
preparation, OC use, menstruation and time in menstrual cycle may affect this
association [5, 7, 25, 45-49]. Several studies considered some of these factors, but
no study to date has considered all of them [25-27]. Finally, some of these studies
included only pregnant women [32, 41]. A study in which non-pregnant women are
included, potentially important covariables are considered and which uses the
diagnostic reference standard will help elucidate the relationship between vaginal
lactobacilli and trichomoniasis.
Estrogen and trichomoniasis
8Another unresolved question about trichomoniasis and the vaginal
microenvironment concerns the influence of sex hormones. Oral contraceptive use
has been positively associated with chlamydia cervicitis and vaginal candidiasis in
prospective cohort, case-control and cross-sectional studies [6, 8, 50, 51]. Two such
studies adjusted for potential confounding variables such as sexual activity [6, 7].
These findings may be due to an increased number of endocervical epithelial cells
available to C. trachomatis for attachment in OC users, since OC use is associated
with cervical ectopy [30]. Furthermore, studies using animal models suggest that
sex hormones enhance growth of C. trachomatis [6].
In contrast, use of OCs is thought to have an inverse relationship with BV and
some PID-associated organisms [8, 30, 50, 51]. Depo-Provera (DP) may also be
inversely associated with BV [6]. Oral contraceptive use may protect against PID-
associated pathogens or may decrease susceptibility to some pathogens by
thickening the cervical mucous [30, 52]. Modulation of vaginal infections and their
clinical severity by endogenous hormones has also been implicated. Vulvovaginal
candidiasis and Mycoplasma genitalium are present more often, and candidiasis
symptoms are exacerbated, during certain times of the menstrual cycle [53, 54].
Conflicting results concerning the effect of estrogens on trichomoniasis have
been reported. In vitro data have shown that Tv growth and cytoadherance are
decreased in the presence of estrogen [55]. Epidemiologic data are consistent with
these in vitro observations. An inverse relationship between trichomoniasis and OC
use was reported by investigators using different study designs and both wet mount
microscopy and Tv culture-confirmed diagnoses [5, 7, 46, 56-59]. In a prospective
9cohort study that adjusted for covariables such as sexual behavior and
demographics, OC users had 0.56 times the risk of acquiring trichomoniasis
compared to women with an intra-uterine device (IUD) or surgical sterilization (95%
CI: 0.39-0.81) [7]. Three other studies employed only univariable analyses, but also
found that OC users were less likely to have trichomoniasis compared to non-OC
users and users of other contraceptive methods [5, 46, 57]. Although it has not been
well researched, one study found an inverse relationship between trichomoniasis
and DP, a contraceptive containing progesterone [6]. Collectively, these data imply
exogenous sex hormones may protect against trichomoniasis.
Conversely, in vitro data have shown that estrogen increases growth of Tv
and that estrogenization is required to establish infection in animal species that are
not natural hosts for the pathogen [60-62]. One study reported that a high
estrogenic state was required to establish Tv infection in castrated human volunteers
[60]. Finally, a clinical case report supports this hypothesis; a metronidazole-allergic
postmenopausal woman was cured of trichomoniasis upon discontinuation of
estrogen replacement therapy [63]. Positive associations between estrogen and Tv
have not been reported in epidemiologic studies. However, some research has
found no statistically significant difference in trichomoniasis between OC users and
non-users [6, 8, 46, 50, 64-66]. These studies also used different designs and
diagnostic methods, and only 1 performed multivariable analyses. This evidence
questions the existence and/or direction of an association between exogenous
estrogen and trichomoniasis.
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Biological interaction of Tv and estrogen is physiologically plausible and some
epidemiologic evidence implies that OC use may protect against acquisition of
trichomoniasis. No study to date has fully explored the relationship between
exogenous sex hormones and trichomoniasis using reference standard diagnostics
while examining potentially important covariables.
Summary
Research presented in this dissertation provides insight into the
interrelationship between trichomoniasis and the vaginal microenvironment. Use of
the diagnostic reference standard, adequate sample size and consideration of
covariables for effect measure modification and confounding are an improvement
over many prior studies on these topics. The association of vaginal lactobacilli and
trichomoniasis could have implications for Tv management, while the effect of OC on
trichomoniasis may influence a woman’s contraceptive choice and might have
implications for the HIV epidemic.
CHAPTER 2: RESEARCH DESIGNS AND METHODS
Specific Aim 1
Evaluate the association between Lactobacillus spp. vaginal Gram stain score
and trichomoniasis.
Study design: Overview
Data were obtained from the prospective case-control study “Trichomonas
vaginalis Infection in the Sexual Partners of Infected Women”, which was conducted
from 2001 to 2003 among female patients and their male sexual partners presenting
to sexually transmitted disease (STD) clinics at three public health departments
located in North Carolina and Alabama. Five hundred thirty-nine women with
trichomoniasis and 177 uninfected women participated in the study. Trichomoniasis
was diagnosed in women who had either a positive wet mount microscopy or Tv
culture result. Women were considered to be Tv-negative if both wet mount
microscopy and Tv culture were negative. All study participants underwent a routine
medical history and evaluation by research staff and completed a provider-
administered questionnaire. This study was approved by the University of North
Carolina at Chapel Hill (UNC-CH) and University of Alabama (UAB) Institutional
Review Boards.
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Study setting
Durham and Wake counties, NC and Jefferson County, AL STD clinics serve
socio-demographically similar patients. The racial/ethnic composition is
approximately 75% black, 15% white and 10% Hispanic. The median patient age for
women is 25 years and the estimated prevalence of Tv infection among women
ranges from 16-22%.
Study population
Demographics: Most women in the study attended the Jefferson Country
Health Department (55%), the others were roughly divided between the two North
Carolina health departments. The majority of women in the study were black (91%)
and most were less than 35 years of age (65%). A sizeable portion (35%) was not
employed, and most female participants had never been married (74%).
Approximately half the participants had a household income in the previous year
less than $12,000, and less than half (34%) obtained education beyond high school.
During the physical exam, clinicians found at least one clinical sign
suggestive of an STI in many women. The most common sign was abnormal
vaginal discharge (79%), followed by abnormal cervical discharge (17%) and
abnormal vaginal erythema (14%). Clinical specimens for STI testing were obtained
from consenting women. The most common STIs were chlamydia (9%) and
gonorrhea (8%).
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Recruitment: All female patients were offered prescreening for the study
based on criteria listed below:
• At least 18 years of age
• English-speaking
• No prior enrollment in the study
• Verbal consent to Tv culture
• Verbal consent to vaginal Gram stain
Women with positive wet mount microscopy results were recruited to participate in
the study. Following recruitment of every third woman positive for trichomoniasis,
the next prescreened woman with negative wet mount microscopy results was
recruited to participate. Study inclusion was dependent upon the following criteria:
• At least 18 years of age
• English-speaking
• No prior enrollment in the study
• History of vaginal sex with men in the past 60 days
• No treatment with topical or oral metronidazole in the 4 weeks prior to Tv
culture collection
• A positive wet mount microscopy or culture result for Tv, or
• Selection as a Tv negative control
• Written consent for the study
Study exclusion criteria were as follows:
• History of treatment with topical or oral metronidazole in the 4 weeks prior to
Tv culture collection
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• A history of domestic violence with current sexual partners
• Pregnancy
• Prior prescreening/enrollment in the study
Data collection
Medical History: Research personnel asked all participants about their
medical history. The medical history covered the following topics: reason for visit,
STI history, number of sexual partners in past 60 days, number of sexual encounters
in past two weeks and condom use.
Physical Exam: Research staff performed a physical exam on all participants.
During the physical exam, inguinal lymph nodes, vulva and perineum were inspected
for lesions, the vagina was evaluated for discharge and erythema, the cervix was
evaluated for discharge and friability and a bimanual pelvic exam was performed to
assess cervical motion or adnexal tenderness. A vaginal swab for wet mount
microscopy and Gram stain was collected and vaginal pH was measured using a pH
strip. Additional STI tests were offered to all participants as per standard clinic
protocols.
Questionnaire: In addition to the routine medical history and physical exam, a
questionnaire was administered by trained interviewers to all participants in a
confidential location. Topics discussed in the questionnaire included reason for the
visit, potential barriers to seeking medical care, STI history, current symptoms,
demographic information such as age, race/ethnicity, level of education, income,
sexual history, sexual behaviors, first day of last menstrual period (LMP) and
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douching behaviors. Interviewers were unaware of the infection status of the
participants.
During the interview, each participant was asked about contraceptive use
during vaginal sex in the past two months with their most frequent and most recent
partner(s). Women were asked specifically about the following contraceptive
methods: IUD, OC, DP injections and Norplant. Each participant was also asked
“When was the first day of your last menstrual period?” To obtain douching
information, participants were asked “Have you douched in the last two months?”,
“How many times have you douched in the last week?” and “How many times do you
douche in an average or usual week?” Participants were also asked what kind of
preparation they usually used when they douche.
Laboratory Evaluation: For wet mount microscopy, a vaginal swab was
obtained according to routine standard of care during speculum examination.
Vaginal swabs were placed into a sterile tube containing 0.5 mL of normal saline
upon collection. The tube was agitated in the laboratory and a drop of the solution
was then placed on a glass slide, covered with a cover slip and examined under the
microscope at 200X magnification.
All study participants were offered chlamydia, gonorrhea, syphilis and HIV
testing per standard clinic protocol. Chlamydia testing was performed using enzyme
immune assay, DNA hybridization or ligase chain reaction (LCR). One clinic
performed enzyme immunoassay (EIA) for C. trachomatis on all female patients; the
others performed LCR for detection of Chlamydia trachomatis for women under the
age of 25 years. Assays were performed according to the manufacturers’ 
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instructions. N. gonorrheae was detected by culture or DNA hybridization. Syphilis
testing was conducted using standard serologies (rapid plasma regain and
microhemagglutination assay for Treponema pallidum). HIV tests were performed
by the state laboratories.
For Tv, a vaginal swab was placed in a 15 mL conical centrifuge tube with a
screw-cap for delayed inoculation into the InPouch culture (Biomed Diagnostics, San
Jose, CA). InPouch cultures were read each day by research personnel at each
health department until transport to the research labs at UNC-CH or UAB. Cultures
were read for 5 days. Using the 20X objective, at least 5 microscopic fields were
examined per pouch at each reading.
For Gram stain of vaginal flora, a vaginal smear was obtained by rolling a
swab across the vaginal wall and then onto a glass slide. Vaginal smears were sent
to the UAB research lab on a monthly basis. The smears were fixed and stained,
and each slide was evaluated for large Gram-positive rods (indicative of lactobacilli)
under oil immersion (1000X magnification) and interpreted using criteria described
by Nugent [1].
Measurements
Exposure: Lactobacillus spp. vaginal Gram stain score: Lactobacillus spp. 
vaginal Gram stain score was determined, using criteria previously described in the
literature [1]. This variable was dichotomized into two groups: 30 large Gram-
positive rods (Lactobacillus spp. morphotypes) per oil immersion field vs. 30 large
Gram-positive rods (Lactobacillus spp. morphotypes) per oil immersion field.
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Bivariable analyses were performed in parallel with Lactobacillus spp. vaginal Gram
stain score coded as an indicator and dichotomous variable. Coding did not
appreciably change the results, so dichotomous coding was used in multivariable
analyses to optimize precision and ease of interpretation.
Outcome: Trichomoniasis diagnosis using the reference standard: The
presence of at least one motile trichomonad at any culture reading defined a positive
culture result. The absence of motile trichomonads at all culture readings defined a
negative culture result. Specimens with motile trichomonads observed by wet mount
microscopy were classified as a positive wet mount microscopy result. Those
without motile trichomonads were classified as a negative wet mount microscopy
result. The primary outcome, diagnosis of trichomoniasis, is a dichotomous variable.
Women with positive wet mount microscopy or Tv culture results were classified as
having trichomoniasis. Women with negative wet mount microscopy results and a
negative Tv culture result were classified as not having trichomoniasis.
Covariables: Age was calculated from the study date and date of birth. It
was initially coded as a continuous variable and then categorized into clinically
reasonable age groups. Race/ethnicity was originally coded categorically using
indicator variables for white, black and other race/ethnicity. It was then
dichotomized into black and other race/ethnicity. The highest level of education for
each participant was ascertained. This information was dichotomized for women with
high school education and women with >high school education. To measure
household income, each participant was asked how much money people in their
household brought in (before taxes) in the previous year. This covariable was then
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dichotomized into <$12,000 and >$12,000. Level of endogenous estrogen was
estimated using the qualitative marker of time during menstrual cycle. The
interviewer recorded the day, month and year of the LMP reported by the participant.
Since there is no accepted definition of high versus low level of estrogen throughout
the menstrual cycle, and responses to this question from an expert panel of
gynecologists differed, this variable was assessed in several ways. Ultimately, the
coding schemes did not substantially change the results, so we dichotomized this
variable into menstrual cycle days 6-14 (“higher estrogen”) and menstrual cycle days
1-5 and 15-28 (“lower estrogen” days).
Gonorrhea, chlamydia, syphilis and HIV were diagnosed according to the
methods described previously. Yeast was diagnosed by wet mount microscopy and
BV was diagnosed by the Nugent Gram stain method [1]. These covariables were
coded dichotomously. All participants were asked if they had ever been diagnosed
with gonorrhea, chlamydia, syphilis, trichomoniasis, BV, cervicitis, PID, genital warts.
genital herpes and HIV. Each STI covariable was coded dichotomously. Whether or
not the patient had douched in the past 2 months was included as a dichotomous
covariable. Number of times participants douched in the past week was also
considered. The following categories of usual douching preparation were also
examined as a nominal variable: water only, water plus baking soda, water plus
vinegar, store bought preparation and other preparation. The interviewer indicated a
positive or a negative response to use of each type of contraception. Sexual activity
was assessed using dichotomized variables of the number of different sex partners a
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woman had in the past year and the number of times she has sex in an average
week.
Data management and data analysis
Data management: The data were collected on three ply paper from the NCR
Corporation. Two plies were sent to the data management group and one ply
remained at each site. All required data were entered using a validated clinical
database management system with double data entry.
Data analysis: We examined the frequency distribution of trichomoniasis
diagnosis, Lactobacillus spp. score and categorical covariables. Measures of central
tendency and variability were also assessed for continuous variables. Additionally,
we reviewed the data for missing and unusual values as well as extreme
distributions.
Bivariable data analysis is useful for identifying potential effect modifiers and
confounding variables. Since a dose-response relationship between decreasing
categories of Lactobacillus spp. score and diagnosis of trichomoniasis is biologically
reasonable, we performed a chi-square test for trend in order to assess a linear
relationship between the two variables. Also, the assumption of linearity in the logit
was assessed in this manner for all ordinal and continuous variables in the analysis.
Next, we evaluated potential effect modification using stratum-specific odds ratios
(OR)s to assess substantive differences and the Breslow-Day Test for Homogeneity
to appraise statistically significant differences between the estimates across levels of
covariables. The OR and 95% CI for the association between Lactobacillus spp.
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vaginal Gram stain score and being diagnosed with trichomoniasis was estimated at
each level of every covariable. Differences in estimates were informally compared,
and whether or not the 95% CI included the estimate from an adjacent stratum was
evaluated. Estimates were then tested for statistically significant differences using
the Breslow-Day Test set at =0.20. Results indicating substantive differences and
which resulted in p-values < 0.10 were considered as effect modifiers in the
multivariable analyses.
Variables that met the criteria to potentially confound the exposure-outcome
relationship were assessed using a stratified tabular approach [67]. Crude and
adjusted ORs (ORcrude- ORadjusted / ORadjusted ) were compared, and those variables
for which the difference was > 0.10 were considered to potentially confound the main
association.
Age, race/ethnicity, high/low estrogen day of menstrual cycle, other STI
diagnosis, douching in previous week, number of times douches in usual week,
douching preparation usually used and OC use were all considered for potential
effect measure modification and/or confounding for specific aim 1.
Multivariable analyses
Multiple logistic regression was performed. A backward elimination model
building strategy was used, which allows for assessment of the joint effects by
covariables. The starting (full) model included the exposure, outcome and all
covariables as well as exposure-covariable interaction terms created based on
results from the bivariable analyses. Interaction terms were assessed first by
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creating a reduced model (without the interaction term) and comparing likelihood
ratio (LR) tests from the two models. The ORs from the two models were also
informally compared for substantive differences. If the LR p-value was  0.10 and
the interaction term was deemed substantively different, the interaction term was
retained in the model. If the LR p-value was > 0.10 and the term was deemed to not
be substantively different, the interaction term was dropped from the model. The
order in which interaction terms were evaluated was based on their p-values (the
term with the largest p-value was assessed first).
Next, potential confounding was assessed by comparing the crude and
adjusted OR for each potential confounding variable. We considered covariables
resulting in |ln(ORcrude/ORadjusted)| > 0.10 as potential confounders and these were
retained in the model. Otherwise the covariables were dropped from the model.
Again, the order in which covariables were assessed for confounding based on their
p-value was the same as described above for effect modification.
The final model contained the exposure and outcome variables along with
any covariables identified as effect modifiers (and their interaction terms) and those
identified as potentially confounding the exposure-outcome association.
Summary: Specific aim 1
This aim utilized multiple logistic regression analysis to examine the
association between level of vaginal lactobacilli and prevalent Tv infection in women.
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Specific Aim 2
Assess the association between oral contraceptive use and trichomoniasis
among women.
Study design
Please refer to study design, specific aim 1.
Study setting
Please refer to study setting, specific aim 1.
Data collection
Please refer to data collection, specific aim 1.
Measurements
Please refer to measurements, specific aim 1.
Data management and analysis
Please refer to data management and analysis, specific aim 1.
Summary: Specific aim 2
This aim compared OC use between women with and without trichomoniasis.
CHAPTER 3:
THE ASSOCIATION BETWEEN TRICHOMONAS VAGINALIS INFECTION AND
LEVEL OF VAGINAL LACTOBACILLI AMONG NON-PREGNANT WOMEN
Abstract
Background
Trichomoniasis is an important public health issue. Many factors influencing
acquisition, presentation and pathogenesis of Tv are not understood. The vaginal
microenvironment and lactobacilli affect many STI, but their impact on
trichomoniasis is not known.
Setting
Three STD clinics located in public health departments in the Southeast US.
Methods
Five hundred twenty one consenting female clinic patients who met eligibility
criteria and were positive for trichomoniasis were recruited into the study. The
control group of 176 women was selected from symptomatic and asymptomatic
women who were not diagnosed with trichomoniasis who presented to the clinics for
evaluation during the study period. All study participants underwent physical
examination and routine STI testing. An in-person questionnaire was also
administered to gather demographic and behavioral information.
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Results
After adjusting for age, race, education, concurrent BV, concurrent gonorrhea
and/or syphilis, number of sex partners in the past 2 months, number of times the
woman has sex in an average week, and OC use, lower levels of vaginal lactobacilli
were positively associated with Tv among women with greater than a high school
education (OR=4.6; 95% CI, 2.2-9.7). Trichomonas vaginalis was not independently
associated with lower levels of vaginal lactobacilli among women with less than or
equal to a high school education after adjusting for potentially confounding variables
(OR=1.5; 95% CI, 0.7-3.5).
Conclusion
Vaginal lactobacilli may be associated with trichomoniasis in subgroups of
women. Whether lower levels of vaginal lactobacilli predispose women to
trichomoniasis or Tv infection leads to lower levels of lactobacilli is not known.
Introduction
Trichomoniasis is the most common curable STI world-wide [2]. The
prevalence of Tv infection in women in the US ranges from 6%-54%, depending on
the population [3]. Trichomoniasis can lead to health problems such as PID and
preterm delivery in women [12, 16]. Furthermore, Tv is a risk factor for HIV [4]. Until
recently, trichomoniasis has received little clinical and research attention, despite its
public health importance. While the vaginal microenvironment is known to influence
other STIs, it has not been well-studied in trichomoniasis [31-33].
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Lactobacillus species are the most prevalent organism in normal human
vaginal flora and may protect the vagina against infection [27]. Lactobacilli produce
antimicrobial compounds as well as lactic acid, creating an environment that is
inhospitable to some pathogenic bacteria [31]. The association between Tv and
lactobacilli is not understood. The addition of lactobacilli to in vitro Tv culture slows
growth of the protozoa and Tv phagocytizes lactobacilli [34-36]. However,
epidemiological evidence is inconsistent. In several early studies, trichomoniasis
was associated with an alkaline vaginal pH, indicating low levels of vaginal
lactobacilli [37, 39, 40, 68]. Later studies also suggest an association between
vaginal lactobacilli and trichomoniasis [41-44]. However, other studies found no
association between vaginal lactobacilli and trichomoniasis [25, 26].
We conducted a case-control study to assess the association between
vaginal lactobacilli and Tv among non-pregnant women. Clarifying this relationship
could improve our understanding of Tv and may have implications for treatment of
trichomoniasis.
Methods
Study design and sample
We conducted a prospective, case-control study in 3 health department STD
clinics located in Durham and Raleigh, North Carolina and Birmingham, Alabama
from November 2001 to July 2003. Female patients who were 18 years old, spoke
English and had not previously been prescreened or enrolled in the study were
eligible for prescreening. Prescreened patients with positive Tv wet mount
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microscopy results were recruited immediately. Prescreened patients with negative
Tv wet mount microscopy results but positive Tv culture results were requested to
return for treatment and/or counseling and were recruited for the study during that
clinic visit. The control group was selected from symptomatic and asymptomatic
women presenting to the STD clinics for evaluation during the study period and were
defined as women found to be uninfected with Tv by wet mount. Patients who were
subsequently diagnosed with trichomoniasis by culture were reclassified as a case.
We recruited 1 woman with a negative Tv wet mount microscopy result for every
third subject with a positive wet mount microscopy enrolled in the study. Recruited
women who had a history of vaginal sex within past 60 days and had not used
metronidazole in the 4 weeks before Tv culture collection were eligible for study
enrollment. All enrolled participants provided written informed consent. The study
was approved by the UNC-CH and the UAB Biomedical Institutional Review Boards.
Clinical, demographic and behavioral data
Two vaginal swabs, 1 for Gram stain and 1 for Tv culture, were obtained from
prescreened women. Vaginal wet mount and routine testing for N. gonorrheae and
syphilis were performed. Routine testing for C. trachomatis was also performed, but
1 clinic limited it to women aged 25 years. All female subjects underwent a
physical examination involving their inguinal lymph nodes, vulva, perineum, vagina
and cervix, and a bimanual pelvic examination assessing for cervical motion or
adnexal tenderness. Clinical information was obtained from their medical records.
Furthermore, research personnel administered detailed questionnaires about
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demographics, clinical symptoms, STI history, douching behavior, sexual behavior
and contraceptive use.
Laboratory Analyses
Wet mount microscopy was performed according to routine clinic procedures
by trained laboratory personnel at each site. T. vaginalis culture was performed
using the InPouch TV culture system (Biomed, White City, OR). Cultures were read
daily up to 5 days following inoculation. Vaginal smears were sent to UAB for Gram
Stain evaluation and were interpreted using Nugent’s criteria [1]. Gonorrhea testing
was performed using culture or DNA hybridization. Syphilis testing was conducted
using standard serologies (rapid plasma reagin). Confirmatory syphilis testing was
performed with microhemagglutination assay for Treponema pallidum.
Statistical Analyses
All data were double-entered by data management personnel into a SAS
version 8 database (SAS Corporation, Cary, NC). We conducted descriptive
analyses of the study population by examining the frequency distribution of Tv,
Lactobacillus spp. score on the vaginal Gram stain and categorical covariables.
Measures of central tendency and variability were assessed for continuous
covariables.
We defined trichomoniasis, the primary study outcome, based on positive wet
mount microscopy or Tv culture results. Women with negative wet mount
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microscopy results and negative Tv culture results were defined as not being
infected with Tv.
The level of vaginal lactobacilli was measured by the Lactobacillus spp.
vaginal Gram stain score using criteria described in the literature [1]. We classified
women who had 30 lactobacillus morphotypes per oil immersion field (Lactobacillus
spp. vaginal Gram stain score of 4+) as having “high” levels of vaginal lactobacilli.
Women who had 0 to 30 lactobacillus morphotypes per oil immersion field
(Lactobacillus spp. vaginal Gram stain score of 0 to 3+) were classified as having
“low” levels of vaginal lactobacilli [1].
We used bivariable analyses to evaluate potential effect measure modification
and confounding of the association between vaginal lactobacilli level and Tv. Effect
measure modification was assessed using the Breslow-Day Test of Homogeneity.
Variables that indicated substantive differences and resulted in p-values <0.20 were
assessed in the multivariable analyses for effect measure modification. Variables
that were associated with both Lactobacillus spp. vaginal Gram stain score and Tv
were considered to potentially confound this association. We evaluated these
variables using a stratified tabular approach [67].
To describe the association between level of vaginal lactobacilli and infection
with Tv in multivariable analyses, an adjusted OR and 95% CI were estimated using
unconditional multiple logistic regression.
We used a backward elimination model building strategy. Interaction terms
were assessed by comparing the LR for the models with and without the interaction
term. Variables resulting in LR p-value 0.10 were retained in the model.
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Confounding of the association between Lactobacillus spp. vaginal Gram stain score
and Tv was assessed by comparing the fully adjusted OR to the adjusted OR after
removal of potentially confounding variables until the cumulative change in the OR of
the exposure was >10%. We evaluated variables in order of the magnitude of the
Wald chi-square test p-value and did not include variables with >20% missing data in
the multivariable analyses.
Results
Study population
Seven hundred ninety women were diagnosed with Tv. Of these, 539
(68.4%) infected women participated in the study and 521 (66.0%) were included in
the present analyses (18 were excluded due to missing data). Of the 203 women
negative for Tv recruited for the study, 177 (87.2%) agreed to participate and one
was excluded due to missing data.
The median age of participants was 27 years old (standard deviation, 9 years)
and most were non-Hispanic Black (91%) (Table 3.1). Half reported a household
income of $12,000 in the previous year and 35% had graduated from high school
or had passed the General Educational Developmental test. Almost half (48%) of
the participants had douched in the past 2 months. Of those who had, most used a
commercial preparation (75%).
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Association between vaginal lactobacilli level and T. vaginalis
Low levels of vaginal lactobacilli were positively associated with Tv in
bivariable analyses (OR=2.2; 95% CI: 1.4-3.2) and remained so after adjusting for
age, race, education, concurrent BV, concurrent gonorrhea and/or syphilis (a marker
of sexual behavior), number of sex partners in the past 2 months, number of times
the woman has sex in an average week, and OC use (Adjusted odds ratio
[AOR]=2.8; 95% CI: 1.5-5.0).
Multivariable analyses suggested that level of education modifies the
association between vaginal lactobacilli level and Tv (p=0.02, LR) (Table 3.2).
Among women with greater than a high school education, low levels of vaginal
lactobacilli were positively associated with Tv (OR=3.3; 95% CI: 1.8-5.9). This
association was not observed in women with at most a high school education
(OR=1.1; 95% CI: 0.6-2.0). After adjusting for the same cofactors as those in the
bivariable analyses (except for educational level), low levels of vaginal lactobacilli
remained positively associated with Tv among women with greater than a high
school education (OR=4.6; 95% CI, 2.2-9.7). Trichomonas vaginalis was not
independently associated with low levels of lactobacilli among women with less than
or equal to a high school education after adjusting for potentially confounding
variables (OR=1.5; 95% CI, 0.7-3.5). See Table 3.2 for these associations.
Adjustment of the final model for chlamydia coinfection and for prior Tv infection did
not substantially alter our results.
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Discussion
Trichomoniasis is the world’s most common curable STI and an apparent
contributor to HIV acquisition [2, 4, 19]. Yet trichomoniasis remains poorly
understood [2, 19, 69]. The relationship between vaginal lactobacilli and Tv remains
unclear, though it could impact important aspects of infection. For example,
abnormal vaginal flora following cervico-vaginal conditions and antimicrobial
treatment of these conditions may promote infection relapse. Exogenously applied
live lactobacilli and oestriol have been shown to help restore normal vaginal
microflora [70]. A clearer understanding of the role of lactobacilli in the natural
history of Tv may help refine this therapy and could possibly improve Tv treatment.
Anaerobic metabolism of vaginal glycogen by lactobacilli produces lactic acid
and H2O2, and may influence virulence of pathogens [27-29]. For example, lack of
vaginal lactobacilli has been positively associated with acquisition and presence of
cervico-vaginal conditions, including BV, chlamydia, gonorrhea and HIV-1 [26, 27,
31-33]. Thus, women with decreased or absent vaginal lactobacilli may be more
likely to acquire or have cervico-vaginal conditions.
The relationship between vaginal lactobacilli and Tv is not understood. In
vitro data suggest an association between the vaginal microorganisms [34-36] while
results from epidemiologic studies are inconsistent [25, 27, 32, 39-44, 68].
Discrepant study results may be due to use of different diagnostic methods to define
Tv infection including wet mount microscopy [26, 39, 45], Tv culture [27, 40, 43], wet
mount microscopy and Tv culture [31, 32, 42, 44, 46] and Pap smear [41].
Furthermore, most studies failed to comprehensively assess the influence of
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covariables on the association between lactobacilli and Tv [5, 7, 25, 45-49]. Finally,
some studies included only pregnant women, whose vaginal flora differs from non-
pregnant women [32, 41, 71] while others were conducted with small sample sizes
[27, 31].
In this study, lower levels of vaginal lactobacilli were positively associated
with prevalent Tv. Association of vaginal lactobacilli level and Tv varied between
women with different levels of education. Among women with a lower educational
level ( high school), Tv was not independently associated with low levels of vaginal
lactobacilli. Among women with greater than a high school education, Tv was
associated with low levels of vaginal lactobacilli after adjusting for covariables that
could potentially confound this relationship.
The reason for the observed difference in effect between educational levels is
unclear. Education may be a proxy for another factor that we did not measure or did
not measure well. Perhaps educational level is a marker for general health status. If
this were the case women with lower educational levels (and relatively poorer
health) may already have health problems, such as abnormal vaginal flora or
general immune suppression, so that a reduction in vaginal lactobacilli would not be
a strong enough biological insult to influence Tv status. However, in the higher
educational group (with better general health) having lower levels of vaginal
lactobacilli might be a strong enough biological insult to have an effect on Tv status.
Given the relative imprecision of these education-specific estimates, this observation
may also have been due to chance.
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Douching has been associated with changes in vaginal flora and cervico-
vaginal conditions, including Tv, making it an important variable to consider in
studies of vaginal flora and trichomoniasis [25, 46, 72-75]. Despite this, there are
limited data on this topic [25, 27]. We considered general douching frequency and
preparation in our analyses, but neither variable appreciably affected the association
between vaginal lactobacilli and Tv. Therefore, douching does not appear to explain
the observed association in this study.
We were unable to explore the temporality of vaginal lactobacilli level and Tv.
Although we observed an association between levels of vaginal lactobacilli and Tv
among certain groups of women, prospective studies are needed to clarify whether
low levels of vaginal lactobacilli are a risk factor for Tv acquisition or whether Tv
causes levels of vaginal lactobacilli to decrease, perhaps via phagocytosis [35, 36].
Furthermore, vaginal flora are dynamic. Daily variability of vaginal flora has
been associated with variables such as use of vaginal medication and spermicides
[47]. Because of this, the level of lactobacilli measured in this study may not reflect
the level of lactobacilli present when the participant was infected with Tv.
Several researchers have reported no association between H2O2-producing
lactobacilli and Tv, though these studies relied on univariable analyses or were
limited by sample size [26, 27, 31]. We were unable to examine this question
because we did not identify strains of vaginal lactobacilli.
Finally, since Tv is not reportable nationally, its scope and demographics in
the US are not definitively known, though it is thought to affect women with a
demographic profile similar to those diagnosed with bacterial STIs. Women in this
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study were recruited from 3 public STI clinics in the US Southeast and, therefore,
may not accurately represent all US women infected with trichomoniasis. Although
we cannot determine if these results are nationally representative, they may be
representative of the most relevant regional population, since the Southeast US has
a disproportionately high prevalence of STIs [76].
Our results suggest that lower levels of vaginal lactobacilli are associated with
presence of Tv in subgroups of women, and that this relationship is not explained by
other measured demographic, clinical or behavioral factors. Understanding this
relationship may improve our knowledge of the pathogenesis, acquisition and
management of trichomoniasis.
35
Table 3.1 Characteristics of women in the study
Characteristic N (%)
Age, year
18-24 273 (39.17)
25-29 132 (18.94)
30-34 95 (13.63)
35-39 86 (12.34)
40-44 74 (10.47)
45 38 (5.45)
Race/ethnicity
Black, non-Hispanic 633 (90.82)
Other 64 (9.18)
Last years' household income (n=648)
<$12,000 324 (50.00)
$12,000 324 (50.00)
Education
 high school graduate or equivalent 454 (65.14)
> high school graduate or equivalent 243 (34.86)
Marital status
Single, never married 514 (73.74)
Married 64 (9.18)
Separated 40 (5.74)
Divorced 73 (10.47)
Widow 6 (0.86)
Level of vaginal lactobacilli
0-30/field 563 (80.77)
30/field 134 (19.23)
Number of times patient has sex/average week (n=674)
1 614 (91.10)
0 60 (8.90)
Number of sex partners in past 2 months (n=696)
2 219 (31.47)
1 477 (68.53)
Bacterial vaginosis status
positive 362 (51.94)
negative 335 (48.06)
Coinfection with gonorrhea and/or syphilis (n=647)
yes 65 (10.05)
no 582 (89.95)
Patient diagnosed with STI in past1 (n=694)
no/don't know 147 (21.18)
yes 547 (78.82)
Oral contraceptive use2 (n=693)
yes 79 (11.40)
no 614 (88.60)
Condom use2 (n=686)
yes 306 (44.61)
no 380 (55.39)
Douched in past 2 months (n=694)
yes 336 (48.41)
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no 358 (51.59)
Number of times patient douches/average week (n=627)
1 time 86 (13.72)
0 times 541 (86.28)
Usual douching preparation3 (n=326)
commercial preparation 246 (75.46)
water+vinegar 67 (20.55)
other 13 (3.99)
1other than trichomoniasis
2with most recent and/or frequent sexual partner
3among women who douched in past 2 months
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Table 3.2 Association between level of vaginal lactobacilli and T. vaginalis infection
Odds Ratio (95% CI)
Education
Vaginal
lactobacilli N
T. vaginalis +
(%) Unadjusted Adjusted1
Any educational level
High2 134 61.94 1.00 1.00
Low3 563 77.80 2.15 (1.44-3.22) 2.75 (1.53- 4.96)
 high school graduate
or equivalent
High 67 79.10 1.00 1.00
Low 387 80.10 1.06 (0.56-2.02) 1.52 (0.67-3.47)
> high school graduate
or equivalent
High 67 44.78 1.00 1.00
Low 176 72.73 3.29 (1.83-5.90) 4.57 (2.15-9.72)
1Adjusted for race/ethnicity, age, diagnosis of bacterial vaginosis, coinfection with gonorrhea and/or syphilis, condom use with most
frequent and/or recent sexual partner, oral contraceptive use, number of times has sex in average week, number of sex partners in
past 2 months
230/field
3
<30/field
CHAPTER 4: ORAL CONTRACEPTIVE USE AND TRICHOMONAS VAGINALIS
INFECTION IN WOMEN
Abstract
Background
Trichomonas vaginalis is the most common non-viral STI worldwide. Over 80
million women use OC, and OC are known to influence other STI. Some studies
suggest OC use may be protective against Tv, while other studies found no
protective effect.
Setting
Three STD clinics located in public health departments in the Southeast US.
Methods
Five hundred twenty one consenting female clinic patients who met eligibility
criteria and were positive for trichomoniasis were recruited into the study. The
control group of 176 women was selected from symptomatic and asymptomatic
women who were not diagnosed with trichomoniasis who presented to the clinics for
evaluation during the study period. All study participants underwent physical
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examination and routine STI testing. An in-person questionnaire was also
administered to gather demographic and behavioral information.
Results
The OR for OC use and trichomoniasis was 0.6, 95% CI 0.3-1.0, after
adjusting for race/ethnicity, highest educational level attained, condom use,
concurrent BV, level of vaginal lactobacilli, number of sex partners in the past year
and number of times the woman has sex in an average week.
Conclusion
Oral contraceptive use appears to be moderately protective against Tv.
Introduction
Trichomonas vaginalis is the most common non-viral STI worldwide.
Furthermore, Tv has been associated with health problems ranging from adverse
pregnancy outcomes and cervical cancer to an increase in HIV transmission [2-4,
19, 59].
The effect of OC use on Tv is of particular interest because over 80 million
women worldwide use OC. Oral contraceptive use affects the acquisition of other
reproductive tract conditions, such as chlamydia, gonorrhea, candidiasis and BV [6,
8, 30, 50, 51, 58, 64, 77]. Results from previous studies on OC use and Tv are
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conflicting [5-8, 46, 56, 57, 65, 66, 78]. This could be due, in part, to differences in
diagnostic and analytic methods and study populations. The objective of this
analysis was to clarify the relationship between OC use and prevalent Tv in non-
pregnant women.
Methods
Study design and sample
This prospective, case-control study was conducted from November 2001 to
July 2003. Participants were recruited from three STD clinics located in Durham and
Raleigh, North Carolina and Birmingham, Alabama health departments. Eligible
female patients for prescreening were English-speaking, 18 years of age, and had
no history of previous prescreening or study enrollment. Women who were
prescreened and had a positive Tv wet mount microscopy test were recruited into
the study at that time. Women were eligible for study enrollment if they had not used
metronidazole for 4 weeks prior to, and had a history of vaginal sex within 60 days of
Tv culture collection. Women who were prescreened with negative Tv wet mount
microscopy but positive Tv culture results were contacted to return to the clinic for
treatment and/or counseling. These women were recruited into the study at their
return visit. The control group was selected from symptomatic and asymptomatic
women presenting to the STD clinics for evaluation during the study period, and
were defined as women found to be uninfected with Tv by wet mount. Patients who
were subsequently diagnosed with trichomoniasis by culture were reclassified as a
case. We recruited 1 woman with a negative Tv wet mount microscopy result for
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every 3 subjects with positive wet mount microscopy results enrolled in the study.
All enrolled participants provided written informed consent. The study was approved
by the UNC-CH and the UAB Biomedical Institutional Review Boards.
Clinical, demographic and behavioral data
Vaginal swabs for Tv culture and Gram stain were collected from prescreened
women. A routine pelvic exam and vaginal wet mount were performed on all
women. Routine testing for N. gonorrheae and syphilis were performed. Clinical,
demographic and behavioral data were obtained from medical records and an in-
person questionnaire administered by research personnel.
Laboratory Analyses
T. vaginalis culture was performed using the InPouch TV culture system
(Biomed, White City, OR) and was read daily up to 5 days after inoculation.
Laboratory personnel performed wet mount microscopy at each study site. Testing
for gonorrhea was conducted by N. gonorrheae culture or DNA hybridization.
Syphilis testing was performed using standard serologies (rapid plasma reagin and
microhemagglutination assays for T. pallidum). Vaginal smear Gram stain was
performed and evaluated at UAB, using Nugent’s criteria [1].
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Measures
We defined Tv infection as women with positive wet mount microscopy or Tv
culture results. Women with negative wet mount microscopy results and negative Tv
culture results were defined as not being infected with Tv.
We considered women who used OC with their most recent and/or most
frequent sexual partner to be on OC. Women who did not use OC with their most
recent and/or frequent sexual partner were classified as not being on OC.
Statistical Analyses
SAS version 8 (SAS Corporation, Cary, NC) was used for data analyses. All
data were double entered. Univariable analyses of the study population were
conducted using frequency distributions of categorical variables. Measures of
central tendency and variability were assessed for continuous variables.
Variables assessed for potentially modifying or confounding the association
between OC use and Tv included demographics (race/ethnicity, last year’s
household income, highest educational level attained), sexual behavior (past
diagnosis with an STI other than Tv, concurrent diagnosis of gonorrhea and/or
syphilis, condom use in the past 2 months, number of different sex partners in the
past year and number of times the woman has sex in an average week), douching
behavior (number of times in the past week, number of times in an average week)
and factors related to the vaginal microenvironment (concurrent diagnosis with BV,
level of vaginal lactobacilli).
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We initially tested each covariable for EMM and confounding by creating a
model with the exposure variable and one additional covariable, and comparing it to
a model containing only the exposure variable. Variables with substantive
differences in OR and a LR p-value 0.10 were assessed in the multivariable
analyses for EMM. Variables that resulted in at least a 10% change in the OR were
evaluated in multivariable analyses for confounding.
Adjusted prevalence OR and 95% CI for the association of interest was
estimated using unconditional multiple logistic regression. We used a backward
elimination strategy and evaluated variables in order of the magnitude of the Wald
chi-square test p-value. Effect measure modification was evaluated by comparing
the LR for the models with and without the interaction term and retaining variables
with a LR p-value 0.10. Confounding was assessed by comparing the fully
adjusted OR to the adjusted OR after removal of potentially confounding variables
until the cumulative change in the OR of the exposure was >0.10.
We also performed sensitivity analyses. We assessed the robustness of the
exposure definition by comparing the exposed group (OC users) to three alternative
reference groups: exclusive condom users, non-OC users excluding women on
other hormone-containing contraceptives and non-OC users excluding condom
users. Since the relationship between vaginal lactobacilli, sex hormones and Tv is
complex, we evaluated the impact of omitting vaginal lactobacilli from the final
model. Finally, we estimated the influence an unmeasured confounder (being in a
stable relationship) could have on our observed association between OC use and Tv
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[79]. We assumed the prevalence of being in a stable relationship was 0.70 in the
study population.
Results
Study population
Seven hundred ninety women were diagnosed with Tv. Of these, 539 (68%)
infected women participated in the study and 539 (68%) were included in the present
analyses. Of the 203 women negative for Tv recruited for the study, 177 (87%)
agreed to participate.
The median age of women in this study was 27 years (standard deviation, 9
years). Most women were black (91%) and had a high school level of education or
less (66%). Last year’s household income was less than $12,000 for half of the
women in the study. The majority of women had previously been diagnosed with an
STI other than Tv (78%) and had more than 1 sex partner in the past year (66%).
Most women did not use OC (89%), while slightly more than half reported using
condoms with their most recent and/or frequent sexual partner (55%) (Table 4.1).
Bivariable Associations with T. vaginalis
Older women were more likely to have prevalent trichomoniasis compared to
women 18-24 years (women 35-39 years OR=2.1, 95% CI 1.2-3.9, 40-44 years
OR=3.6, 95% CI 1.6-7.7, 45 years OR=8.0, 95% CI 1.9-33.9) (Table 4.2). Women
who were black were more likely to be infected with Tv compared to non-blacks
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(OR=2.6, 95% CI 1.5-4.3), as were women with a lower level of education (OR=2.2,
95% CI 1.5-3.0), women with a lower household income (OR=1.8, 95% CI 1.3-2.6)
and women with a lower level of vaginal lactobacilli (OR=2.2, 95% CI 1.4-3.2).
Having had a past STI diagnosis, concurrent BV diagnosis, condom use and
douching in the previous week were not associated with Tv infection status (Table
4.2).
Association between oral contraceptive use and T. vaginalis
In bivariable analyses, we observed an inverse association between OC use
and prevalent Tv (OR=0.5, 95% CI: 0.3-0.8) (Table 4.2). Adjusting for potentially
confounding covariables, including race/ethnicity, highest educational level attained,
condom use, concurrent BV, level of vaginal lactobacilli, number of sex partners in
the past year and number of times the woman has sex in an average week, did not
substantially change the relationship (OR= 0.6, 95% CI 0.3-1.0) (Table 4.3).
Women who used OC with their most recent and/or most frequent sexual
partner were considered to be exposed and women who did not use OC with their
most recent and/or frequent sexual partner were classified as not being exposed.
Examination of the bivariable association between OC use and Tv using the
alternative reference groups yielded similar results: exclusive condom users
(OR=0.6, 95% CI 0.3-1.0), non-OC users excluding other methods of hormonal
contraceptives (OR=0.5, 95% CI 0.3-0.8), non-OC and non-condom users (OR=0.4,
95% CI: 0.2-0.7). The association between OC and Tv may be due to differing
sexual behavior between OC users and non-users, such as being in a stable
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relationship. We assessed sexual behavior with several variables, but did not have
information on relationship stability. Therefore, we estimated the impact that this
variable could have on our results. Assuming the prevalence of being in a stable
relationship is 0.70 in the study population, the association between being in a stable
relationship and OC use would have to be quite high (OR 5.0) to negate the
observed protective effect. Finally, since vaginal lactobacilli may be in the causal
pathway between OC and trichomoniasis, we excluded it from our model to assess
its impact on our results. Omitting vaginal lactobacilli from the final model did not
appreciably change our results (OR=0.5, 95% CI: 0.3-0.9).
Discussion
Sex hormones, such as estrogen, are known to affect STI [80]. How estrogen
might effect Tv has not been determined. Trichomonas vaginalis possesses
estrogen receptors, and addition of estrogen to Tv in culture slows growth of the
organism and decreases attachment to mammalian cells [9, 10, 55]. This evidence
suggests estrogen could decrease infectivity of Tv. However, results from studies
performed in animals imply that estrogen might increase infectivity in vivo [9]. For
example, animals that were not natural hosts for Tv required treatment with estrogen
before establishing infection [61].
Most OC contain estrogen and are thought to influence vaginal conditions and
susceptibility to infection, including chlamydia, vaginal candidiasis and BV [6-8, 30,
57, 64, 81]. While this question has been previously examined for Tv, study results
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are variable. In this investigation, OC use was moderately protective against
prevalent Tv.
Our findings are consistent with several other studies about the relationship
between Tv and OC, which also found a protective effect [5, 7, 56-59]. However,
other studies have not demonstrated a relationship between OC use and Tv status
[6, 8, 64-66, 78]. This discrepancy in results may be due to the use of different
diagnostic and analytical methods. For example, some studies used wet mount
microscopy to diagnose Tv [5-7, 56-58]. Since wet mount microscopy is a less
sensitive diagnostic technique compared to culture, results from these studies could
be biased towards the null. Other studies employed only bivariable analyses [5, 8,
31, 57, 66]. Although we did not observe significant confounding in this study, it is
possible that confounding may have influenced the results of previous studies.
The difference in Tv risk between OC users and non users may be due to
differing sexual behaviors. However, this does not appear to be the case in this
study. Our analyses included several variables related to sexual behavior (past
diagnosis with an STI other than Tv, condom use, number of partners women had in
the past year and number of times the woman has sex in an average week).
Furthermore, adjustment of our final model with marital status and number of years
in a sexual relationship with their most frequent partner did not substantively change
our results.
The effect of OC use on cervical mucosa may protect OC users against
infection [7]. However, Tv mainly infects the lower reproductive tract, so changes in
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cervical mucosa may not have a substantial impact on trichomoniasis. In this case,
changes in cervical mucosa would not explain our results.
Alternatively, female sex hormones are known to affect the reproductive tract
immune response [82-85]. While the pathogenic mechanisms of Tv are not well
understood, OC could possibly alter host defenses to Tv. For example, Tv infects
vaginal epithelium, which may be thicker in women using OC compared to women
not on hormonal contraception. On the other hand, OC use does not appear to
affect frequency or composition of vaginal intraepithelial immune cells, so changes in
vaginal epithelium due to OC use may not explain the observed results [86-89].
Finally, although it appears that estrogen decreases growth of Tv in vitro, it
may promote growth in vivo. In a case report, a metronidazole-allergic
postmenopausal woman was reported to have elimination of Tv after discontinuation
of estrogen replacement therapy [63]. Establishment of an estrogenic state in
hysterectomized women and animals has also been reported [63]. If estrogen is
growth-promoting in vitro, we might expect to observe a positive association
between OC and Tv. However, OC users appear to have low serum levels of
endogenous estrogen [86]. Serum levels of endogenous estrogen were also
comparatively lower among OC users versus women who did not use hormonal
contraceptives [86]. An inverse association between OC and Tv could be explained
if OC use results in a net reduction of systemic and/or local estrogen in women. An
alternative explanation of the observed protective effect of OC is that estrogen from
OC competes with endogenous estrogen for Tv estrogen receptors [7]. If
endogenous estrogen promotes Tv growth, perhaps exogenous estrogen
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competitively binds to Tv estrogen receptors, impeding the stimulating effect of
endogenous estrogen.
In our study, we did not collect information regarding the duration of OC use.
Thus, it is possible that Tv may have occurred before OC use, resulting in exposure
misclassification. We also lacked information on OC composition. Most OC include
a combination of estrogen and progesterone, though progesterone-only
prescriptions exist. While the level of estrogen in different types of OC may differ,
the amount is fairly constant between birth control pills [85]. Oral contraceptive
misclassification should be non-differential with respect to Tv status and any
resulting bias should be towards the null [67].
Moreover, Tv status may have been misclassified because of the imperfect
performance of Tv culture. Although considered the diagnostic reference standard,
Tv culture has imperfect sensitivity compared to Tv nucleic acid amplification testing.
Thus, some Tv diagnoses may have been missed. Again, this misclassification
should be non-differential with respect to OC status, and the resulting bias should
lead to an underestimation of the true association.
Finally, estrogen-containing contraceptives stimulate vaginal epithelial cells to
produce more glycogen, creating a favorable environment for vaginal lactobacilli
[71]. If vaginal lactobacilli is in the causal pathway between OC use and Tv, the
observed effect would be biased toward the null, and it should not be adjusted for in
multivariable analyses [67]. However, exclusion of this variable from our model
yielded similar results, suggesting that the effect is not mediated through this
pathway.
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Millions of women world-wide use contraception, and knowledge that
contraceptives impact STI may affect a woman’s contraceptive choice. We found
OC use to be moderately protective against prevalent Tv. Given the popularity of
OC, the high burden of Tv in certain populations and the variety of health problems
associated with Tv, prospective studies are warranted to confirm these results.
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Table 4.1 Characteristics of women in the study (n=716)
Characteristic N (%)
T. vaginalis infection yes 539 (75.28)
no 177 (24.72)
(n=712)
Oral contraceptive use1 yes 81 (11.38)
no 631 (88.62)
(n=407)
Endogenous estrogen (menstrual
cycle days) 1-5 28 (6.88)
6-10 83 (20.39)
11-14 79 (19.41)
15-25 172 (42.26)
26-28 45 (11.06)
Age (year) 18-24 282 (39.39)
25-29 135 (18.85)
30-34 97 (13.55)
35-39 89 (12.43)
40-44 74 (10.34)
45 39 (5.45)
Race/ethnicity
Black, non-
Hispanic 651 (90.92)
Other 65 (9.08)
(n=665)
Household income, last year <$12,000 330 (49.62)
$12,000 335 (50.38)
Highest attained education
high
school
graduate or
equivalent 469 (65.50)
>high
school
graduate or
equivalent 247 (34.50)
(n=697)
Level of vaginal lactobacilli 0-30/field 563 (80.77)
30/field 134 (19.23)
(n=692)
Number of times has sex, average
week 1 628 (90.75)
0 64 (9.25)
(n=697)
52
Bacterial vaginosis yes 362 (51.94)
no 335 (48.06)
(n=702)
Number of times douched, past week 0 times 542 (77.21)
1 time 129 (18.38)
2 times 31 (4.42)
(n=705)
Condom use1 yes 388 (55.04)
no 317 (44.96)
(n=713)
Past STI diagnosis2
no/don't
know 155 (21.74)
yes 558 (78.26)
(n=715)
Number of sex partners, past year 1 246 (34.41)
1 469 (65.59)
1with most recent and/or frequent sexual partner
2other than trichomoniasis
53
Table 4.2 Characteristics of women with and without T. vaginalis infection1 (N=716)
Women with Women without
trichomoniasis trichomoniasis
(N= 539) (N=177)
Characteristic n(%) n(%) OR (95%CI)
Oral contraceptive
use2 yes 50 (61.73) 31 (38.27) 0.48 (0.30-0.78)
no 486 (77.02) 145 (22.98) 1.00
Endogenous
estrogen higher estrogen3 127 (39.94) 191 (60.06) 1.03 (0.63-1.66)
lower estrogen4 35 (39.33) 54 (60.67) 1.00
Age (year) 18-24 197 (69.86) 85 (30.14) 1.00
25-29 94 (69.63) 41 (30.37) 0.99 (0.63-1.55)
30-34 71 (73.20) 26 (26.80) 1.18 (0.70-1.98)
35-39 74 (83.15) 15 (16.85) 2.13 (1.16-3.92)
40-44 66 (89.19) 8 (10.81) 3.56 (1.64-7.74)
45 37 (94.87) 2 (5.13) 7.98 (1.88-33.87)
Race Black, non-Hispanic 502 (77.11) 149 (22.89) 2.55 (1.51-4.31)
Other 37 (56.92) 28 (43.08) 1.00
Education high school graduate/GED 377 (80.38) 92 (19.62) 2.15 (1.52-3.04)
>high school graduate/GED 162 (65.59) 85 (34.41) 1.00
Household
income, last year <$12,000 265 (80.30) 65 (19.70) 1.79 (1.25-2.55)
$12,000 233 (69.55) 102 (30.45) 1.00
Level of vaginal
lactobacilli 0-30/field 438 (77.80) 125 (22.20) 2.15 (1.44-3.22)
30/field 83 (61.94) 51 (38.06) 1.00
Number of times
has sex,
average week 1 464 (73.89) 164 (26.11) 0.40 (0.19-0.87)
0 56 (87.50) 8 (12.50) 1.00
Bacterial vaginosis yes 271 (74.86) 91 (25.14) 1.01 (0.72-1.43)
no 250 (74.63) 85 (25.37) 1.00
Past STI
diagnosis5 yes 419 (75.09) 139 (24.91) 0.98 (0.65-1.48)
no/don't know 117 (75.48) 38 (24.52) 1.00
Condom use2 yes 233 (73.50) 84 (26.50) 0.80 (0.57-1.13)
no 301 (77.58) 87 (22.42) 1.00
Number of times
douched,
past week 0 times 138 (80.23) 34 (19.77) 1.00
1 time 104 (80.62) 25 (19.38) 1.03 (0.58-1.82)
2 times 26 (83.87) 5 (16.13) 1.28 (0.46-3.58)
1infection was defined as having a positive wet mount microscopy and/or T. vaginalis culture
2with most recent and/or frequent sexual partner
3menstrual cycle days 6-14
4menstrual cycle days 15-28 and 1-5 
5other than trichomoniasis
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Table 4.3 Association between oral contraceptive use and T. vaginalis infection
Odds Ratio (95% CI)
N Unadjusted Adjusted
Oral contraceptive use1 yes 81 0.48 (0.30-0.78) 0.56 (0.32-0.97)2
no 631 1.00 1.00
1with most recent and/or frequent sexual partner
2adjusted for race/ethnicity, highest educational level attained, condom use, concurrent bacterial vaginosis diagnosis,
level of vaginal lactobacilli, number of sex partners, past year; number times woman has sex, average week
CHAPTER 5: DISCUSSION
Summary of Findings
Despite the fact that for many years it was considered a nuisance infection,
the public health impact of trichomoniasis, the most common curable STI worldwide,
is substantial [2, 11, 15]. Trichomoniasis is associated with preterm birth, low birth
weight and premature rupture of the membranes [15, 90, 91]. T. vaginalis infection
has also been implicated in the development of cervical neoplasia, tubal infertility
and posthysterectomy infection [3, 14, 18]. Finally, trichomoniasis appears to
increase both HIV acquisition and transmission [4, 15]. Although the prevalence in
urban STD clinics is estimated to be close to 25%, trichomoniasis is not a reportable
condition in the US [15].
For this dissertation, we examined the association of two aspects of the
vaginal microenvironment, lactobacilli and estrogen, on prevalent trichomoniasis.
We compared the prevalence of trichomoniasis in women with lower versus higher
levels of vaginal lactobacilli and found that the association differed by educational
level. Among women with greater than a high school education, lower levels of
vaginal lactobacilli were positively associated with Tv, while this association was not
observed in women with at most a high school education.
The effect of estrogen on trichomoniasis was assessed by estimating the
association between OC use and trichomoniasis. Use of OC was found to be
moderately protective against Tv infection.
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Vaginal Lactobacilli and Trichomoniasis
Vaginal lactobacilli are the most common microorganisms in the healthy
human vagina and are affected by many factors, ranging from sexual behavior to
douching agents [25, 26]. Lack of vaginal lactobacilli has been positively associated
with conditions such as BV, gonorrhea, HIV and chlamydia, possibly due to the
production of lactic acid and H2O2 by vaginal lactobacilli [31-33]. Trichomonas
vaginalis is thought to produce metabolic substances that are toxic against
lactobacilli and is known to phagocytize lactobacilli, suggesting an association
between low levels or absence of lactobacilli and Tv [92]. However, the
epidemiologic data are inconsistent, and evidence for an association between
vaginal lactobacilli and trichomoniasis is inconclusive.
Elucidation of the association between vaginal lactobacilli and Tv is worth
seeking for two reasons. First, relatively little is known about the pathogenesis of
trichomoniasis and factors that influence its’ acquisition. Information concerning the
influence of vaginal lactobacilli, the predominant vaginal microorganism in most
women, on Tv could improve our understanding of both pathogenesis and
acquisition of trichomoniasis. Secondly, restoration of vaginal microflora following
cervico-vaginal conditions can affect relapse of infection, an especially pertinent
issue for a condition that is often asymptomatic and may have a long duration of
infectiousness [3, 46, 93]. Since exogenously applied live lactobacilli (in
combination with estradiol) have been shown to help restore normal vaginal
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microflora, a clearer understanding of the role of lactobacilli in the natural history of
Tv may help refine this therapy and could possibly improve Tv treatment [70].
In vitro data suggest lactobacilli have a deleterious effect on Tv, but
epidemiologic studies have produced conflicting results [34-36, 92]. In several
studies trichomoniasis was associated with low levels of vaginal lactobacilli [32, 41-
44]. However, in two studies that examined the association between H2O2 -
producing lactobacilli and Tv infection, no statistically significant association was
observed [26, 27, 31]. Another study that did not distinguish strain of lactobacillus
failed to find an association between the presence of Lactobacillus spp. and Tv [25].
These discrepant results may be due to issues such as use of different diagnostic
methods, failure to assess variables that could confound or modify the association
and study population. Another factor could be the use of different comparison
groups. For example, 2 of the studies that failed to find an association between
vaginal lactobacilli and trichomoniasis compared H2O2-producing versus non- H2O2-
producing strains of lactobacilli whereas other studies compared levels of all
lactobacilli strains. Furthermore, 2 of the studies that found no association between
vaginal lactobacilli and Tv included only 7 and 26 Tv-positive participants, and 1 was
performed in pregnant women.
In this study, the association between vaginal lactobacilli and Tv infection
varied by educational level. Among women with a lower level of education, Tv was
not independently associated with low levels of vaginal lactobacilli. However, among
women with greater than a high school education, low levels of vaginal lactobacilli
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were positively associated with trichomoniasis, after adjusting for measured factors
that could confound this relationship.
The reason for this difference is not clear and cannot be determined from the
available data. Education may be a proxy for another variable. Alternatively, the
observed effect modification by education could be due to chance.
Estrogen and Trichomoniasis
Sex hormones, such as estrogen, are known to affect STI. The effect of OC
use on Tv is of particular interest because over 80 million women worldwide use OC.
Oral contraceptive use affects the acquisition of other reproductive tract conditions,
such as chlamydia, gonorrhea, candidiasis and BV [6, 8, 30, 50, 51, 58, 64, 77]. In
order to make an informed decision about contraception, women should be informed
about implications of OC on STI.
Results from previous epidemiologic studies on OC use and Tv are conflicting
[5-8, 46, 56, 57, 65, 66, 78]. Our results are consistent with several cross-sectional
studies that found an inverse association between OC use and Tv, although these
studies used wet mount microscopy for diagnosis [5, 7, 56-58]. Another cross-
sectional study used culture to diagnose Tv and also reported a protective effect of
OC use, but this study was performed among pregnant women [59]. Finally, one
prospective study reported a statistically significant inverse association between OC
and trichomoniasis, although this study diagnosed Tv with wet mount microscopy
and compared OC users to IUD users or women who had had a tubal ligation [7].
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Several of these studies used multivariable analyses to adjust for potentially
confounding variables [7, 56, 58, 59].
Other researchers have found no effect of OC use on Tv infection [6, 8, 46,
50, 64-66]. Several of these studies used wet mount microscopy to diagnose Tv, but
most used culture. Only 1 study was prospective, but it relied on wet mount
microscopy and its study population was Kenyan prostitutes [6]. Only 1 of these
studies used multivariable analyses [6].
The reason for the discrepancy in results cannot be determined. Perhaps the
use of different study populations, diagnostic techniques or comparison groups
contributes to this phenomenon. Only 1 of the studies that failed to find a protective
effect of OC use used multivariable analyses, suggesting that important covariables
may need to be considered when studying this association. However, in our study,
the crude OR differed only slightly from the adjusted OR, implying that confounding
did not substantially influence this relationship in our study population.
While sex hormones, such as estrogen, are known to affect STI, the
mechanisms by which estrogen might affect Tv has not been determined [80].
Trichomonas vaginalis possesses estrogen receptors, and addition of estrogen to Tv
in culture slows growth of the organism and decreases attachment to mammalian
cells [9, 10, 55]. Therefore, estrogen may decrease infectivity of Tv. However,
results from in vivo studies suggest that estrogen might promote infectivity [9]. For
example, estrogenization was required in animals who were not natural hosts of Tv,
before Tv infection could be established [61, 94].
60
It has been suggested that an association between OC and Tv could be due
to differences in sexual behavior between OC users and non-users [59]. This could
be true, however, we adjusted for several variables related to sexual behavior.
The observed inverse association may also be explained by the effect of OC
on the immune response to Tv, since female sex hormones are known to affect the
reproductive tract immune response [82-85]. For example, women on OC may
have thicker vaginal epithelia-the site of Tv infection- compared to women not on
OC. However, OC use does not appear to impact the frequency and composition of
vaginal intraepithelial immune cells [86-89].
It is also possible that systemic and/or local levels of estrogen are lower in
women on OC. If estrogen promotes Tv growth in vivo, as some research has
suggested, an inverse association between OC and Tv could be explained by a net
reduction in estrogen among women on OC [63, 86]. Finally, assuming estrogen
increases growth in vivo, estrogen from OC may compete with endogenous estrogen
for Tv estrogen receptors [7].
Future Research Directions
The data from this study in combination with others suggest that there is an
association between Tv and low levels of vaginal lactobacilli. To the best of our
knowledge, the present study is the first to examine this relationship using culture-
confirmed cases of Tv and multivariable analyses that considered potentially
important covariables such as douching. A prospective study would help clarify the
temporality of this relationship: do low levels of vaginal lactobacilli predispose
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women to Tv acquisition or, once infected, does Tv lead to the destruction of vaginal
lactobacilli, which leads to low levels of vaginal lactobacilli in women with
trichomoniasis? Such a study should enroll non-pregnant women and have different
age and racial groups well-represented. It should also diagnose Tv by culture or
polymerase chain reaction. All participants should complete a comprehensive
questionnaire including questions on demographics, sexual behavior and douching.
Vaginal lactobacilli should be evaluated at baseline and regularly during follow-up. In
addition to measuring the level of vaginal lactobacilli, using criteria such as that
described by Nugent, it may be helpful to distinguish H2O2-positive and negative
species [1]. While such a study would be expensive and complex, it could target all
STI, to improve the understanding of these complicated relationships.
If low levels of vaginal lactobacilli do predispose women to Tv infection,
further research could be focused on the impact of maintenance of healthy vaginal
flora on Tv acquisition and prevention. If Tv leads to low levels of vaginal lactobacilli,
future studies might address the potential impact screening for Tv could have on
other conditions associated with abnormal vaginal flora, such as preterm birth.
A prospective study examining the associations between OC and Tv would
also be helpful to further our understanding of the relationship between estrogen and
Tv. Information on OC formulation and duration would add to the analyses, as
would data on menstrual cycle regularity. Sufficient statistical power would also
enable researchers, without much additional study effort, to examine the effect of
progesterone-only contraceptives on Tv. Developing a good animal model for
studying Tv would also be valuable, because it can be difficult to generalize in vitro
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data to humans. Studies on the effect of OC on circulating and local levels of
estrogen and how it influences the vaginal immune response would also be useful.
Given the prevalence of Tv worldwide, research concerning the public health
impact of Tv screening, particularly in populations with a high prevalence of Tv and
HIV should be a high priority. If additional studies substantiate the protective effect
of OC against Tv, it may be helpful to examine the potential role OC could play in the
HIV epidemic. This topic is complicated since OC has been associated with an
increased prevalence of other STI. Finally, public health policy must be changed to
ensure Tv is reportable nationally. Until then, the true burden of trichomoniasis in
the US will not be known.
In summary, my dissertation examined the effect of the vaginal
microenvironment on Tv infection. Both low levels of vaginal lactobacilli and OC use
were associated with trichomoniasis, though in different directions. The temporality
of the relationship between vaginal lactobacilli and Tv remains to be elucidated, and
could have implications for efforts for vaginal flora restoration and/or Tv screening.
The mechanism by which OC protects against Tv also needs to be clarified. This
association may impact women’s contraceptive choice and could possibly play a role
in the HIV epidemic.
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